Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
Vanessa Piechotta(Robert Koch Institute), Nicole Skoetz(Medical University of Vienna), Jannik Stemler(University of Cologne), Caroline Hirsch(University of Cologne), Ina Monsef(University of Cologne), Claire Iannizzi(University of Cologne), Paul J. Bröckelmann(University Hospital Cologne), Oliver A. Cornely(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Nina Kreuzberger(University of Cologne), Sibylle C. Mellinghoff(University of Cologne), Anne Adams, Alice Brinkmann(University of Cologne)
Cited by 43
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Caspofungin versus Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|2004|922